| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Plasmodium falciparum Normocyte binding protein 2a (a.a.61- |
| | 460) |
| | Swiss-Prot #: | Q7JU29 |
| | Entry name: | Q7JU29_PLAFA |
| | Protein | Normocyte binding protein 2a |
| | Gene names: |
| | Organism: | Plasmodium falciparum |
| | Codon-optimized cDNA Clone |
| | Cat#: | RPL-0423 |
| | Description: | Applications:1. Codon-optimized cDNA sequence designed for recombinant |
| | protein production in both E.coli and Mammalian cell. The cDNA has been |
| | cloned into E.coli expression vector with 6x Histidine tag. 2. May be used as |
| | RNAi assistance to restore the loss-of-function. |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Recombinant Protein |
| | Cat#: | PL-0423 |
| | Source: | Recombinant protein derived from E.coli. Or Yeast |
| | Tag: | A 6x histidine tag |
| | Formulation: | Liquid |
| | Purity: | > 90%, as determined by SDS-PAGE under reducing conditions |
| | Activity: | N/A |
| | Applications: | Western Blot, may be used for other applications determined by |
| | Storage: | -20° to -70° C. Avoid repeated freeze-thaw cycles. |
| | Sequence: | | MKTTLFCSIS FCNIIFFFLE LSHEHFVGQS SNTHGASSVT DFNFSEEKNL KSFEGKNNNN DNYASINRLY RKKPYMKRSL |
| | INLENDLFRL EPISYIQRYY KKNINRSDIF HNKKERGSKV YSNVSSFHSF IQEGKEEVEV FSIWGSNSVL DHIDVLRDNG |
| | TVVFSVQPYY LDIYTCKEAI LFTTSFYKDL DKSSITKINE DIEKFNEEII KNEEQCLVGG KTDFDNLLIV LENAEKANVR |
| | KTLFDNTFND YKNKKSSFYN CLKNKKNDYD KKIKNIKNEI TKLLKNIEST GNMCKTESYV MNNNLYLLRV NEVKSTPIDL |
| | YLNRAKELLE SSSKLVNPIK MKLGDNKNMY SIGYIHDEIK DIIKRYNFHL KHIEKGKEYI KRITQANNIA DKMKKDELIK |
| | KIFESSKHFA SFKYSNEMIS KLDSLFIKNE EILNNLFNNI FNIFKKKYET YVDMKTIESK YTTVMTLSEH LLEYAMDVLK |
| | ANPQKPIDPK ANLDSEVVKL QIKINEKSNE LDNAISQVKT LIIIMKSFYD IIISEKASMD EMEKKELSLN NYIEKTDYIL |
| | QTYNIFKSKS NIINNNSKNI SSKYITIEGL KNDIDELNSL ISYFKDSQET LIKDDELKKN MKTDYLNNVK YIEENVTHIN |
| | EIILLKDSIT QRIADIDELN SLNLININDF INEKNISQEK VSYNLNKLYK GSFEELESEL SHFLDTKYLF HEKKSVNELQ |
| | TILNTSNNEC AKLNFMKSDN NNNNNNSNII NLLKTELSHL LSLKENIIKK LLNHIEQNIQ NSSNKYTITY TDINNRMEDY |
| | KEEIESLEVY KHTIGNIQKE YILHLYENDK NALAVHNTSM QILQYKDAIQ NIKNKISDDI KILKKYKEMN QDLLNYYEIL |
| | DKKLKDNTYI KEMHTASLVQ ITQYIPYEDK TISELEQEFN NNNQKLDNIL QDINAMNLNI NILQTLNIGI NACNTNNKNV |
| | EHLLNKKIEL KNILNDQMKI IKNDDIIQDN EKENFSNVLK KEEEKLEKEL DDIKFNNLKM DIHKLLNSYD HTKQNIESNL |
| | KINLDSFEKE KDSWVHFKST IDSLYVEYNI CNQKTHNTIK QQKNDIIELI YKRIKDINQE IIEKVDNYYS LSDKALTKLK |
| | SIHFNIDKEK YKNPKSQENI KLLEDRVMIL EKKIKEDKDA LIQIKNLSHD HFVNADNEKK KQKEKEEDDE QTHYSKKRKV |
| | MGDIYKDIKK NLDELNNKNL IDITLNEANK IESEYEKILI DDICEQITNE AKKSDTIKEK IESYKKDIDY VDVDVSKTRN |
| | DHHLNGDKIH DSFFYEDTLN YKAYFDKLKD LYENINKLTN ESNGLKSDAH NNNTQVDKLK EINLQVFSNL GNIIKYVEKL |
| | ENTLHELKDM YEFLETIDIN KILKSIHNSM KKSEEYSNET KKIFEQSVNI TNQFIEDVEI LKTSINPNYE SLNDDQIDDN |
| | IKSLVLKKEE ISEKRKQVNK YITDIESNKE QSDLHLRYAS RSIYVIDLFI KHEIINPSDG KNFDIIKVKE MINKTKQVSN |
| | EAMEYANKMD EKNKDIIKIE NELYNLINNN IRSLKGVKYE KVRKQARNAI DDINNIHSNI KTILTKSKER LDEIKKQPNI |
| | KREGDVLNND KTKIAYITIQ INNGRIESNL LNILNMKHNI DTILNKAMDY MNDVSKSDQI VINIDSLNMN DIYNKDKDLL |
| | INILKEKQNM EAEYKKMNEM YNYVNETEKE IIKHKKNYEI RIMEHIKKET NEKKKKFMES NNKSLTTLMD SFRSMFYNEY |
| | INDYNINENF EKHQNILNEI YNGFNESYNI INTKMTEIIN DNLDYNEIKE IKEVAQTEYD KLNKKVDELK NYLNNIKEQE |
| | GHRLIDYIKE KIFNLYIKCS EQQNIIDDSY NYITVKKQYI KTIEDVKFLL DSLNTIEEKN KSVANLEICT NKEDIKNLLK |
| | HVIKLANFSG IIVMSDTNTE ITPENPLEDN DLLNLQLYFE RKHEITSTLE NDSDLELDHL GSNSDESIDN LKVYNDIIEL |
| | HTYSTQILKY LDNIQKLKGD CNDLVKDCKE LRELSTALYD LKIQITSVIN RENDISNNID IVSNKLNEID AIQYNFEKYK |
| | EIFDNVEEYK TLDDTKNAYI VKKAEILKNV DINKTKEDLD IYFNDLDELE KSLTLSSNEM EIKTIVQNSY NSFSDINKNI |
| | NDIDKEMKTL IPMLDELLNE GHNIDISLYN FIIRNIQIKI GNDIKNIREQ ENDTNICFEY IQNNYNFIKS DISIFNKYDD |
| | HIKVDNYISN NIDVVNKHNS LLSEHVINAT NIIENIMTSI VEINEDTEMN SLEETQDKLL ELYENFKKEK NIINNNYKIV |
| | HFNKLKEIEN SLETYNSIST NFNKINETQN IDILKNEFNN IKTKINDKVK ELVHVDSTLT LESIQTFNNL YGDLMSNIQD |
| | VYKYEDINNV ELKKVKLYIE NITNLLGRIN TFIKELDKYQ DENNGIDKYI EINKENNSYI IKLKEKANNL KENFSKLLQN |
| | IKRNETELYN INNIKDDIMN TGKSVNNIKQ KFSSNLPLKE KLFQMEEMLL NINNIMNETK RISNTAAYTN ITLQDIENNK |
| | NKENNNMNIE TIDKLIDHIK IHNEKIQAEI LIIDDAKRKV KEITDNINKA FNEITENYNN ENNGVIKSAK NIVDEATYLN |
| | NELDKFLLKL NELLSHNNND IKDLGDEKLI LKEEEERKER ERLEKAKQEE ERKERERIEK EKQEKERLER EKQEQLKKEE |
| | ELRKKEQERQ EQQQKEEALK RQEQERLQKE EELKRQEQER LEREKQEQLQ KEEELKRQEQ ERLQKEEALK RQEQERLQKE |
| | For pricing and availability Click Here >>> |
| | Recombinant-Protein-cDNA-Normocyte-binding-protein-2a-Plasmodium |
| | FOR in vitro RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
|
| ||||||||||||||||||||||||||||||||||
| |||||
| For cDNA or Recombinant Protein Search (Input Cat#, Gene name, Protein Name, Accession Number |
|
Copyright Bioclone Inc All rights Reserved